Adage Capital Partners GP »

Vyne Therapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.1M 644k 1.65
2025-03-31 $544k 344k 1.58
2024-12-31 $516k 154k 3.35

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Procter & Gamble Company (PG)
ConocoPhillips (COP)
Visa Com Cl A (V)

View all positions for Adage Capital Partners GP

Top funds holding Vyne Therapeutics

Baker Bros. Advisors
Acorn Capital Advisors
Shay Capital
Acadian Asset Management
Ikarian Capital
Two Sigma Investments
Vanguard Group
Jane Street
Geode Capital Management
Boothbay Fund Management
Bridgeway Capital Management
Susquehanna International
Two Sigma Advisers
Rangeley Capital
Corsair Capital Management

View all funds holding Vyne Therapeutics